Lam AK - Search Results

1

Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Leung P, Luk JM. Yu XM, et al. Among authors: lam ak. Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447. Ann Surg. 2008. PMID: 18376194

2

Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

Lam AK, Lo CY, Lam KS. Lam AK, et al. Among authors: lam ks. Endocr Pathol. 2005 Winter;16(4):323-30. doi: 10.1385/ep:16:4:323. Endocr Pathol. 2005. PMID: 16627919 Review.

3

Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.

Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Lang BH, et al. Among authors: lam ak. World J Surg. 2006 May;30(5):752-8. doi: 10.1007/s00268-005-0356-7. World J Surg. 2006. PMID: 16680590

4

Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.

Lam AK, Lo CY, Leung P, Lang BH, Chan WF, Luk JM. Lam AK, et al. Ann Surg Oncol. 2007 May;14(5):1772-9. doi: 10.1245/s10434-006-9280-9. Epub 2006 Dec 31. Ann Surg Oncol. 2007. PMID: 17195959

5

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Lang BH, Leung P, Luk JM. Yu XM, et al. Among authors: lam ak. Surgery. 2008 Dec;144(6):934-40; discussion 940-1. doi: 10.1016/j.surg.2008.07.027. Surgery. 2008. PMID: 19041000

6

Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor.

Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH. Tong DK, et al. Among authors: lam ak. Ann Surg Oncol. 2010 Aug;17(8):2184-92. doi: 10.1245/s10434-010-0995-2. Epub 2010 Mar 9. Ann Surg Oncol. 2010. PMID: 20217248 Free PMC article.

7

Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance.

Lam AK, Lau KK, Gopalan V, Luk J, Lo CY. Lam AK, et al. Pathology. 2011 Jan;43(1):40-7. doi: 10.1097/PAT.0b013e328340bb46. Pathology. 2011. PMID: 21240064

8

Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.

Salajegheh A, Pakneshan S, Rahman A, Dolan-Evans E, Zhang S, Kwong E, Gopalan V, Lo CY, Smith RA, Lam AK. Salajegheh A, et al. Among authors: lam ak. Hum Pathol. 2013 Oct;44(10):2204-12. doi: 10.1016/j.humpath.2013.04.014. Epub 2013 Jul 8. Hum Pathol. 2013. PMID: 23845470

9

Factors affecting the approaches and complications of surgery in childhood papillary thyroid carcinomas.

Fridman M, Krasko O, Branovan DI, Dabryian S, Pisarenko A, Lo CY, Lam AK. Fridman M, et al. Among authors: lam ak. Eur J Surg Oncol. 2019 Nov;45(11):2078-2085. doi: 10.1016/j.ejso.2019.07.032. Epub 2019 Aug 1. Eur J Surg Oncol. 2019. PMID: 31395293

10

Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.

Lam AK, Lo CY. Lam AK, et al. Ann Surg Oncol. 2006 Feb;13(2):176-81. doi: 10.1245/ASO.2006.03.062. Epub 2006 Jan 17. Ann Surg Oncol. 2006. PMID: 16411146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters